These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3469553)
1. Economics of screening for cancer of the cervix. Hicks S; Edwards D N Z Med J; 1987 Feb; 100(817):81. PubMed ID: 3469553 [No Abstract] [Full Text] [Related]
2. Economics of screening for cancer of the cervix. Hicks S; Edwards D N Z Med J; 1986 Nov; 99(814):916. PubMed ID: 3468422 [No Abstract] [Full Text] [Related]
3. Economic aspects of screening for cervical cancer in New Zealand. Bethwaite J; Rayner T; Bethwaite P N Z Med J; 1986 Oct; 99(811):747-51. PubMed ID: 3464889 [TBL] [Abstract][Full Text] [Related]
4. Economics of screening for cervical cancer. Coldman AJ; Anderson GH N Z Med J; 1987 Jul; 100(827):425. PubMed ID: 3452069 [No Abstract] [Full Text] [Related]
5. ["Cost-effectiveness" of cervical screening]. Kostova P Akush Ginekol (Sofiia); 2007; 46(6):32-4. PubMed ID: 17974169 [TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the cervix in a country district. Tennent RB; Tennent MS; Philip NA N Z Med J; 1967 Mar; 66(415):Suppl:7-13. PubMed ID: 5228790 [No Abstract] [Full Text] [Related]
7. [Costs and problems in cervix cancer screening are considerably underestimated]. Bistoletti P Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597 [No Abstract] [Full Text] [Related]
8. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands. Boon ME; de Graaff Guilloud JC Acta Cytol; 1981; 25(5):539-42. PubMed ID: 6792845 [TBL] [Abstract][Full Text] [Related]
9. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer? Reust CE J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567 [No Abstract] [Full Text] [Related]
10. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial]. Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766 [No Abstract] [Full Text] [Related]
11. Screening the hard to reach: improving morbidity and mortality from cervical cancer in New Zealand. Sykes P; Sadler L; Priest P N Z Med J; 2008 Jul; 121(1277):5-7. PubMed ID: 18677325 [No Abstract] [Full Text] [Related]
12. Economics of screening for cancer of the cervix. Bethwaite J; Bethwaite P; Rayner T N Z Med J; 1986 Dec; 99(815):961. PubMed ID: 3468437 [No Abstract] [Full Text] [Related]
13. Cervical screening program for Sri Lanka--can we afford it? Sirisena J Ceylon Med J; 1999 Mar; 44(1):41-5. PubMed ID: 10643099 [No Abstract] [Full Text] [Related]
14. [Cervical cancer screening and associated treatment costs in France]. Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085 [TBL] [Abstract][Full Text] [Related]
15. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity. Hutchinson ML; Berger BM; Farber FL Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402 [TBL] [Abstract][Full Text] [Related]
17. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test]. Bistoletti P Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367 [No Abstract] [Full Text] [Related]
18. Papanicolaou cervical smears for screening in asymptomatic women. Barnes BA Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755 [TBL] [Abstract][Full Text] [Related]
19. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal]. van der Graaf Y Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1569-71. PubMed ID: 12224477 [TBL] [Abstract][Full Text] [Related]
20. Screening for cervical cancer. Duncan GR; Jones RW; Svensen TC N Z Med J; 1985 Sep; 98(787):821. PubMed ID: 3865088 [No Abstract] [Full Text] [Related] [Next] [New Search]